The model also suggested that an anti-inflammatory drug called celecoxib should bind with CDH11, a protein which plays an important role in the development of both rheumatoid arthritis and metastatic breast cancer.
When the antibodies on the surface of the nanotubes come in contact with a target protein, the proteins bind to the tubes and spread them apart a tiny bit.